These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18979520)

  • 1. NK cells: new issues and challenges. Preface.
    Colonna M
    Eur J Immunol; 2008 Nov; 38(11):2927-9. PubMed ID: 18979520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the activating receptor NKG2D in autoimmunity.
    Van Belle TL; von Herrath MG
    Mol Immunol; 2009 Nov; 47(1):8-11. PubMed ID: 19286259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functions of natural killer cells.
    Vivier E; Tomasello E; Baratin M; Walzer T; Ugolini S
    Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell recognition by the NK cell activating receptor NKG2D.
    Bryceson YT; Ljunggren HG
    Eur J Immunol; 2008 Nov; 38(11):2957-61. PubMed ID: 18979516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cells and cancer immunosurveillance.
    Waldhauer I; Steinle A
    Oncogene; 2008 Oct; 27(45):5932-43. PubMed ID: 18836474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can NK cells be a therapeutic target in human cancer?
    Chan CJ; Andrews DM; Smyth MJ
    Eur J Immunol; 2008 Nov; 38(11):2964-8. PubMed ID: 18979512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cell-based cancer immunotherapy.
    Stagg J; Smyth MJ
    Drug News Perspect; 2007 Apr; 20(3):155-63. PubMed ID: 17520092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell tolerance licensing and other mechanisms.
    Jonsson AH; Yokoyama WM
    Adv Immunol; 2009; 101():27-79. PubMed ID: 19231592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-organization of mitochondria at the NK cell immune synapse.
    Abarca-Rojano E; Muñiz-Hernández S; Moreno-Altamirano MM; Mondragón-Flores R; Enriquez-Rincón F; Sánchez-García FJ
    Immunol Lett; 2009 Jan; 122(1):18-25. PubMed ID: 19038287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
    Chen Y; Shi Y; Cheng H; An YQ; Gao GF
    IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for the use of NK cells in immunotherapy of human cancer.
    Ljunggren HG; Malmberg KJ
    Nat Rev Immunol; 2007 May; 7(5):329-39. PubMed ID: 17438573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance?
    Jonjić S; Polić B; Krmpotić A
    Eur J Immunol; 2008 Nov; 38(11):2952-6. PubMed ID: 18979514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
    Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
    Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The unique properties of human NK cells in the uterine mucosa.
    Manaster I; Mandelboim O
    Placenta; 2008 Mar; 29 Suppl A():S60-6. PubMed ID: 18039547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.
    Varchetta S; Oliviero B; Francesca Donato M; Agnelli F; Rigamonti C; Paudice E; Arosio E; Berra M; Rossi G; Tinelli C; Fagnoni FF; Colombo M; Mavilio D; Mondelli MU
    J Hepatol; 2009 Feb; 50(2):314-22. PubMed ID: 19070924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate T cell responses in human gut.
    Meresse B; Cerf-Bensussan N
    Semin Immunol; 2009 Jun; 21(3):121-9. PubMed ID: 19231234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells: diversity in search of a niche.
    Di Santo JP
    Nat Immunol; 2008 May; 9(5):473-5. PubMed ID: 18425102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells in human autoimmunity.
    Flodström-Tullberg M; Bryceson YT; Shi FD; Höglund P; Ljunggren HG
    Curr Opin Immunol; 2009 Dec; 21(6):634-40. PubMed ID: 19892538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.